LILY34:BVMF
Eli Lilly And Company BDR
R$ 199.35
0.00%
(0.00) 1D
7-р сарын 17, 17:06:00 (GMT-3) · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$ 199.62
High
R$ 202.49
Low
R$ 197.04
Mkt. cap
1.11ИН
Avg. vol.
23.96 мян
Volume
16.12 мян
52-wk high
R$ 214.47
52-wk low
R$ 112.45
Shares outstanding
941.74 сая
No. of employees
50 мян
Open
R$ 199.62
High
R$ 202.49
Low
R$ 197.04
Mkt. cap
1.11ИН
Avg. vol.
23.96 мян
Volume
16.12 мян
52-wk high
R$ 214.47
52-wk low
R$ 112.45
Shares outstanding
941.74 сая
No. of employees
50 мян
News stories
From sources across the web
Stocktwits
·
5 цагийн өмнө
ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders
The Globe and Mail
·
12 цагийн өмнө
Cathie Wood Is Loading Up on This GLP-1 Stock That Has Soared 1,600% Over the Past 10 Years
The Motley Fool
·
1 өдрийн өмнө
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
Yahoo Finance
·
2 өдрийн өмнө
The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50 мян
Founded1876
HeadquartersИндианаполис, Индиана, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websitelilly.com
AI content may include mistakes. Learn more